Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Lymphocytes maturing in the thymus (T cells) are key factors in adaptive immunity and the regulation of inflammation. The kynurenine pathway of tryptophan metabolism includes several enzymes and compounds that can modulate T cell function, but manipulating these pharmacologically has not achieved the expected therapeutic activity for the treatment of autoimmune disorders and cancer. With increasing knowledge of other pathways interacting with kynurenines, the expansion of screening methods, and the application of virtual techniques to understanding enzyme structures and mechanisms, details of interactions between kynurenines and other pathways are being revealed. This review surveys some of these alternative approaches to influence T cell function indirectly via the kynurenine pathway and summarizes the most recent work on the development of compounds acting directly on the kynurenine pathway.

More information Original publication

DOI

10.1016/j.tips.2023.04.006

Type

Journal article

Publication Date

2023-07-01T00:00:00+00:00

Volume

44

Pages

442 - 456

Total pages

14

Keywords

3-hydroxyanthranilic acid, AHR, GPR35, IDO, IL4i1, T cells, autoimmunity, cancer therapy, immune tolerance, indoleamine 2,3-dioxygenase, kynurenic acid, kynurenine, tryptophan, Humans, Kynurenine, Tryptophan, T-Lymphocytes, Inflammation, Autoimmune Diseases